SI-BONE, Inc. revealed its preliminary and unaudited revenue figures for the fourth quarter and full year of 2025, showcasing robust financial performance and market growth.
The company reported a significant worldwide revenue of $200.8 to $200.9 million for the full year, marking a remarkable growth rate of approximately 20% compared to the previous year.
In the fourth quarter of 2025, SI-BONE's global revenue ranged from $56.2 to $56.3 million, representing a notable 15% increase from the same period in the prior year.
Strong Worldwide Revenue Growth
SI-BONE's global revenue surged by around 20% in full-year 2025 compared to the previous year, reflecting the company's successful market strategies and product demand.
Robust U.S. Revenue Expansion
The U.S. market was a significant driver of growth for SI-BONE, with a commendable 21% revenue increase in fiscal year 2025, indicating strong acceptance of its offerings in the domestic market.
Expansion in Physician Network
SI-BONE witnessed a noteworthy 18% growth in the number of active physicians in the U.S., totaling approximately 1,640 physicians, signaling increasing adoption of the company's solutions within the medical community.
- SI-BONE's impressive revenue growth in 2025 underscores its strategic positioning and growth trajectory, showcasing its ability to capture market share and drive top-line growth consistently.
- The rise in active physicians using SI-BONE's solutions in the U.S. reflects the growing acceptance and adoption of the company's innovative technologies, indicating a positive outlook for its future revenue streams and market expansion efforts.
SI-BONE's preliminary revenue results for the fourth quarter and full year of 2025 validate a successful period marked by substantial revenue growth and market expansion, particularly in the U.S. market. The company's focus on developing innovative solutions for bone-related clinical challenges has evidently yielded promising financial outcomes, positioning it favorably for continued growth and leadership in the orthopedic market.